key: cord-0899578-t5umv3qt
authors: Koltai, Jonathan; Raifman, Julia; Bor, Jacob; McKee, Martin; Stuckler, David
title: COVID-19 Vaccination and Mental Health: A Difference-in-Difference Analysis of the Understanding America Study
date: 2021-12-16
journal: Am J Prev Med
DOI: 10.1016/j.amepre.2021.11.006
sha: 0d4f79b702fdd7b1a21233285c8cf71f451fb977
doc_id: 899578
cord_uid: t5umv3qt

Introduction: Mental health problems increased during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge that one is less at risk after being vaccinated may alleviate distress but this hypothesis remains unexplored. This study tests whether psychological distress declined in those vaccinated against COVID-19 in the U.S. and whether changes in anticipatory fears mediated any association. Methods: A nationally representative cohort of U.S. adults (n=8,090) in the Understanding America Study were interviewed every 2 weeks from March 2020 to June 2021 (28 waves). Difference-in-differences regression tested whether vaccination reduced distress (Patient Health Questionnaire 4 scores), with mediation analysis used to identify potential mechanisms, including perceived risks of infection, hospitalization, and death. Results: Vaccination was associated with a 0.04-SD decline in distress (95% CI= –0.07, –0.02). Vaccination was associated with a 7.77–percentage point reduction in perceived risk of infection (95% CI= –8.62, –6.92), a 6.91-point reduction in perceived risk of hospitalization (95% CI= –7.72, –6.10), and a 4.68-point reduction in perceived risk of death (95% CI= –5.32, –4.04). Including risk perceptions decreased the vaccination–distress association by 25%. Event study models suggest vaccinated and never vaccinated respondents followed similar Patient Health Questionnaire 4 trends pre-vaccination, diverging significantly post-vaccination. Analyses were robust to individual and wave fixed effects, time-varying controls. The effect of vaccination on distress varied by race/ethnicity, with the largest declines observed among American Indian and Alaska Native individuals (β= –0.20, p<0.05, 95% CI= –0.36, –0.03). Conclusions: COVID-19 vaccination was associated with declines in distress and perceived risks of infection, hospitalization, and death. Vaccination campaigns could promote these additional benefits of receiving the COVID-19 vaccine.

On May 13, 2020, the UN warned that although coronavirus disease 2019 (COVID- 19) was primarily an infectious disease, it was also sowing the "seeds of a major mental health crisis." 1 Surveys in the U.S. reveal elevated levels of psychological distress, anxiety, and suicidal ideation since the onset of the pandemic. [2] [3] [4] [5] [6] Several factors have contributed to these findings, including loss of income and work, food insecurity, social isolation, caregiving burdens, substance use, and racialized discrimination. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] One recent study points to anticipatory fears, with perceived risk of infection and mortality explaining 20.7% of the increased distress between March and June 2020. 19 A recent meta-analysis found that, after peaking in March-April 2020, population distress decreased to pre-pandemic levels by mid-2020. 20 Yet, despite population-level declines in distress, recent research points to persistent depressive symptoms among those reporting an accumulation of COVID-19-induced stressors between March-April 2020 and March-April 2021. 21 Many individuals may also continue to experience anticipatory fears associated with the pandemic, which have been shown to have adverse effects on mental health. 19, 22 As of July 4, 2021, cumulative deaths attributed to COVID-19 had surpassed 600,000 in the U.S., but only 67.1% of adults had received ≥1 dose of a COVID-19 vaccine. A consistent body of evidence now supports the safety of COVID-19 vaccines, as well as their efficacy in preventing infection, serious illness, and death. 23 One critical gap in research is whether being vaccinated reduces COVID-19-related anticipatory fears by reducing the risk of these severe outcomes. If vaccination alleviates fears associated with COVID-19, this may also have salutary spillover effects for mental health. Further, these dynamics may be more pronounced among vulnerable groups whose communities have experienced disproportionate COVID-19-related suffering and loss of life.

Are there individual and social benefits of vaccination beyond preventing infection? One hypothesis, so far unexplored, is whether vaccination improves mental health by reducing anticipatory fears of infection, hospitalization, and death. The present study uses a difference-indifference method with nationally representative longitudinal data to test whether vaccination for COVID-19 reduces psychological distress and, if so, whether lower perceived risk mediates this association. Lastly, this study tests whether the effects of vaccination vary across sociodemographic groups.

This study used data from the Understanding Coronavirus in America study, 24 an extension of an Internet-based, nationally representative longitudinal survey. Twenty-eight survey waves were examined, between March 2020 and June 2021. The primary analysis was restricted to those who participated in ≥2 survey waves with non-missing values for the exposure, outcome, and covariates (n=8,090). Appendix Figure 1 shows a flowchart with these sample inclusion criteria and Appendix Table 1 shows dates and sample sizes for each study wave. Appendix Table 2 shows descriptive characteristics for never vaccinated and vaccinated respondents in the analytic sample. The analyses of de-identified secondary data are considered exempt from IRB approval according to the University of New Hampshire Office of Research, Economic Engagement and Outreach.

The primary exposure was vaccination status, coded as 1 beginning in the first wave in which the respondent answered yes to the question Have you gotten vaccinated for the coronavirus? and imputed as 1 thereafter. It was coded as 0 for no and imputed as 0 in each period prior to Wave 21 (December 23, 2020 to January 18, 2021), the first time this question was asked.

Psychological distress was assessed using the Patient Health Questionnaire (PHQ-4) developed by Kroenke et al., 25 and validated by Lowe and colleagues. 26 Scores on the scale range from 0 to 12, with higher scores indicating greater distress. The main analyses used total PHQ-4 scores standardized to have a mean of 0 and SD of 1. Indicator variables for moderate distress (PHQ-4 ≥6) and severe distress (PHQ-4 ≥9) were also used in supplementary analyses. 25 Participants were asked: On a scale from 0 to 100%, what is the chance that you will get the coronavirus in the next three months? Then: If you do get the coronavirus, what is the percent chance you will be hospitalized (spend at least one night in the hospital) from it? Finally, perceived infection-fatality risk was assessed by asking: If you do get infected with the coronavirus, what is the chance you will die from it? Responses were also recorded as 0%-100%.

In addition to individual and study wave fixed effects, the main analyses were adjusted for several time-varying, self-reported covariates: receiving Supplemental Nutrition Assistance Program benefits in the month prior to the survey, receiving unemployment insurance past 14 days, whether the respondent had been diagnosed with COVID-19, and employment status at the time of the survey.

This study used 2-way fixed effects models to assess the association between receiving a COVID-19 vaccination and changes in mental health. These models take the form: rates. 27 is an indicator variable that switches to 1 in first wave in which the respondent answered yes to the question Have you gotten vaccinated for the coronavirus? and remains as 1 thereafter. To assess how the outcomes of interested changed over time before and after vaccination, this study uses "event study" models. Further details of these event study models are shown in the Appendix.

Appendix Figure 2 shows a gradient in the prevalence of reporting ≥1 dose of vaccination by age, income, and education, with higher rates of vaccination observed among older respondents and those at the higher end of the SES spectrum. Among racial and ethnic groups, Asian and Pacific Islanders had the highest rates of vaccination (79%), followed by Whites (67%), mixed race respondents (61%), American Indian and Alaska Natives (AI/ANs; 59%), Hispanic individuals (59%), and Black respondents (56%).

Appendix Figure 3 shows secular trends in distress scores for never vaccinated respondents and respondents who were vaccinated during the study period. Distress scores increased for both groups at the outset of the pandemic, peaking in Wave 2 (April 1, 2020 to April 27, 2020), and then declined steadily until Wave 7 (June 10, 2020 to July 6, 2020). Event study analyses in Figures 1 and 2 provide additional support for the findings in Table 2 . Table 2 underestimate the true effect. Figure 2 shows slight differences in risk perceptions between vaccinated and never vaccinated respondents in the pre-treatment period, although these were stable over time. Following vaccination, these trends diverged, with vaccinated individuals experiencing large reductions risk perceptions relative to those who were never vaccinated in this sample.

To facilitate interpretation of effect sizes, additional models estimated the effects of health behaviors (alcohol use and exercise) and perceived financial risk on distress in Appendix Table   3 . Here, a 1-day increase in alcohol use per week was associated with a 0.01-SD increase in distress (p<0.001), and a 10-percentage point increase in perceived risk of running out of money in the next 3 months was associated with a 0.03-SD increase in distress (p<0.001). The effect size for the association between vaccination and distress was thus slightly larger than a 10-percentage point increase in perceived financial risk and comparable to a 4-day increase in alcohol use per week.

Supplementary analyses also tested whether the effects of vaccination were heterogeneous across sociodemographic groups, first using stratified analysis to plot coefficients (Appendix Figures 5-9 ) and then by fitting models with statistical interactions between vaccination and each group. Finally, Appendix Table 9 shows the characteristics of the national sample at Wave 1 versus the characteristics of respondents in their final wave in the analytic sample. As Appendix Table 9 shows, these characteristics remained highly similar, suggesting that any attrition across waves was random. Much work remains to be done to promote vaccine uptake in America. As of July 4, only 67.1% of U.S. adults had been vaccinated, 32 falling short of President Biden's target of 70% by the same date, and daily vaccination rates have fallen sharply. 33 Though side effects and safety top the list of concerns of those not vaccinated, lack of information and access remain barriers for vulnerable individuals, particularly Black Americans. 34 Many people of color who are not yet vaccinated express vaccine hesitancy but also high perceived risk from COVID-19 infection. [35] [36] [37] Meanwhile, although the poor and those facing food and housing insecurity are less likely to be vaccinated, many, especially those with children, want a vaccine. 36, 38 Limitations As with all observational analyses, this study has clear limitations. First, measurements of both the distress and vaccination rely on self-report, which may be biased. Second, the web-based Notwithstanding these limitations, this study has several key strengths. First, this is the first study to find large reductions in anticipatory fears following COVID-19 vaccination, with beneficial spillover effects for mental health. Second, the main findings are robust to timevarying controls, individual and wave fixed effects, and several alternative modeling strategies.

Importantly, the analyses were robust to state-by-wave fixed effects, ruling out confounding due 

United Nations Policy Brief: COVID-19 and the Need for Action on Mental Health

Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study

Psychological distress and adaptation to the COVID-19 crisis in the United States

Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic

Anxiety, depression, traumatic stress and COVID-19-related anxiety in the UK general population during the COVID-19 pandemic

Prevalence of mental health problems during the COVID-19 pandemic: a systematic review and meta-analysis

COVID-19 and mental health equity in the United States

Forced social isolation and mental health: a study on 1,006 Italians under COVID-19 lockdown

Association among income loss, financial strain and depressive symptoms during COVID-19: evidence from two longitudinal studies

Job insecurity and financial concern during the COVID-19 pandemic are associated with worse mental health

Economic hardship and mental health complaints during COVID-19

How do state policies shape experiences of household income shocks and mental health during the COVID-19 pandemic?

The implications of COVID-19 for mental health and substance use

for-mental-health-and-substance-use

Initial challenges of caregiving during COVID-19: caregiver burden, mental health, and the parentchild relationship

The disparate impact of COVID-19 on the mental health of female and male caregivers

Anti-Asian discrimination and the Asian-white mental health gap during COVID-19

Vicarious racism and vigilance during the COVID-19 pandemic: mental health implications among Asian and Black Americans

The association between food insecurity and mental health during the COVID-19 pandemic

Explaining the rise and fall of psychological distress during the COVID-19 crisis in the United States: longitudinal evidence from the Understanding America Study

A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020

Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of US adults

Lancet Reg Health Am

The relationship between fear of COVID-19 and mental health problems: a meta-analysis. Death Stud. In press

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

An ultra-brief screening scale for anxiety and depression: the PHQ-4

A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population

Econometric analysis of cross section and panel data

Disparities in the population at risk of severe illness from COVID-19 by race/ethnicity and income

I hope to hell nothing goes back to the way it was before": COVID-19, marginalization, and native nations. Perspectives on Politics

Native Americans And COVID-19 Vaccine Hesitancy: Pathways Toward Increasing Vaccination Rates For Native Communities

Keys to the Navajo Nation's COVID-19 Vaccination Success

COVID-19 Vaccinations in the United States

See How Vaccinations Are Going in Your County and State. The New York Times

Vaccine Monitor

COVID-19 vaccine hesitancy: race/ethnicity, trust, and fear

Public trust and willingness to vaccinate against COVID-19 in the US from

Addressing vaccine hesitancy in BIPOC Communitiestoward trustworthiness, partnership, and reciprocity

Something to celebrate: delivering vaccines to essential workers

Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom

Association between automotive assembly plant closures and opioid overdose mortality in the United States: a difference-in-differences analysis

Association between receipt of unemployment insurance and food insecurity among people who lost employment during the COVID-19 pandemic in the United States

Implementing the panel event study